Fukunaga Keiko Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
■ Presentation
1.
High sensitivity analysis of NPM1 mutation is useful for minimal redidual disease in AML. 2017/10/20
2.
The clinical features and prognostic impact of de novo acute myeloid leukemia with RUNX1 mutation. 2017/10/20
3.
The prognostic impact of FLT3-ITD allelic ratio in de novo acute myeloid leukemia. 2017/10/20
4.
Affect of leucovorin resucue with reduction of toxicity after shot term MTX. 2017/10/21
5.
TK1 management of 2cases of CML with micro RNA transcripts(P230BCR/ABL). 2017/10/22
6.
Prediction of hemorrhagic cystitis using antibody to ADV type11 and prophylastic value of cidofovir 2018/02/03
7.
Granulocyte collections using Spectra Optia with or without the use of hydroxyethy1 starch 2019/03/08
8.
HLA haploidentical transpantation in AYAs 2019/03/08
9.
Isohemagglotinin production after minor ABO-incompatible peripheral blood stem cell transplantation 2019/03/08
10.
Usefulness of measuring hematology analyzer-based HPC in peripheral blood stem cell harvest 2019/03/08
11.
Secondary malignancies after hematopoietic stem cell transplantation in Hyogo college of medicine 2019/03/09
12.
anti-NMDAR encephalitis after HLA haploidentical stem cell transplantation 2020/03/06
13.
Phamacokinetics of cidofovir in Japanese patients receiving hematopoietic stem cell transplantation 2020/03/06
14.
Effect of letermovir on blood concentration of voriconazole 2020/03/07
15.
Decision making in AYA patients with hematological malignancy underwent HLA mismatch transplants. 2021/03
16.
Survival-time analysis using recurrent neural networks in hematopoietic stem cell transplantation 2021/03
17.
Tisagenlecleucel for Diffuse Large B-cell Lymphoma:A Single Center Experience 2021/03
18.
Two cases of incidental plasma cell neoplasm: diagnostic roles of EMA and CD79a immunohistochemistry 2021/09/23